3/25
11:30 am
hook
Hookipa Pharma Inc (NASDAQ: HOOK) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $5.00 price target on the stock.
Low
Report
Hookipa Pharma Inc (NASDAQ: HOOK) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $5.00 price target on the stock.
3/25
08:07 am
hook
Hookipa Pharma Inc (NASDAQ: HOOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.50 price target on the stock.
Low
Report
Hookipa Pharma Inc (NASDAQ: HOOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.50 price target on the stock.
3/24
09:18 am
hook
Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook [Yahoo! Finance]
Low
Report
Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook [Yahoo! Finance]
3/22
07:10 am
hook
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/22
07:01 am
hook
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Low
Report
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
3/6
07:12 am
hook
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference [Yahoo! Finance]
Low
Report
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference [Yahoo! Finance]
3/6
07:01 am
hook
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
Low
Report
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
2/2
01:22 pm
hook
All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy [Yahoo! Finance]
1/30
10:19 am
hook
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $6.00 to $5.00. They now have an "outperform" rating on the stock.
Medium
Report
Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $6.00 to $5.00. They now have an "outperform" rating on the stock.
1/29
08:09 am
hook
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs [Yahoo! Finance]
1/29
08:01 am
hook
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
Medium
Report
HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
1/16
07:15 am
hook
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization [Yahoo! Finance]
Medium
Report
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization [Yahoo! Finance]
1/16
07:01 am
hook
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
Medium
Report
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization